211 related articles for article (PubMed ID: 29575439)
21. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
[TBL] [Abstract][Full Text] [Related]
22. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
23. [Urine cytology in the diagnosis of urothelium tumors].
Rona-Selnic G
Med Lab (Stuttg); 1982; 35(6):158-62. PubMed ID: 7162453
[No Abstract] [Full Text] [Related]
24. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
Kim JM; Lee J; Sung SH
Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
[TBL] [Abstract][Full Text] [Related]
25. Urine cytology in bladder tumors.
Zein TA; Milad MF
Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
[TBL] [Abstract][Full Text] [Related]
26. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
[TBL] [Abstract][Full Text] [Related]
27. [Urinary cytology for the detection of urothelial lesions].
Duchêne L; Davenne É; Lifrange F; Detrembleur N; Delporte G; Waltregny D; Delvenne P
Rev Med Liege; 2024 Jun; 79(5-6):424-428. PubMed ID: 38869134
[TBL] [Abstract][Full Text] [Related]
28. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
[TBL] [Abstract][Full Text] [Related]
29. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
30. [What contribution can make artificial intelligence to urinary cytology?].
Lacoste-Collin L
Ann Pathol; 2024 May; 44(3):195-203. PubMed ID: 38614871
[TBL] [Abstract][Full Text] [Related]
31. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
[TBL] [Abstract][Full Text] [Related]
32. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
33. The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma.
Ordon M; Boerner S; Zlotta AR; Jewett MA; Fleshner N
BJU Int; 2009 Dec; 104(11):1641-5. PubMed ID: 19583723
[TBL] [Abstract][Full Text] [Related]
34. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
[TBL] [Abstract][Full Text] [Related]
35. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
37. Applying the Paris System for Reporting Urine Cytology Increases the Rate of Atypical Urothelial Cells in Benign Cases: A Need for Patient Management Recommendations.
Granados R; Duarte JA; Corrales T; Camarmo E; Bajo P
Acta Cytol; 2017; 61(1):71-76. PubMed ID: 27838683
[TBL] [Abstract][Full Text] [Related]
38. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275
[TBL] [Abstract][Full Text] [Related]
39. When words matter: A "suspicious" urinary tract cytology diagnosis improves patient follow-up among nonurologists.
Fite JJ; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2018 Apr; 126(4):282-288. PubMed ID: 29360190
[TBL] [Abstract][Full Text] [Related]
40. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
Ylagan LR; Humphrey PA
Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
